<DOC>
	<DOC>NCT00796380</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of Xingnaojing for the treatment of convulsive diseases; to investigate whether convulsion episodes can be induced or aggravated by Xingnaojing and the role inflammation plays in the process.</brief_summary>
	<brief_title>Clinical Study of Xingnaojing for the Treatment of Convulsive Diseases</brief_title>
	<detailed_description />
	<criteria>1. Febrile convulsion: positive family history of febrile convulsion; aged between 6 months and 6 years old; in accordance with the diagnosis criteria of simple type of febrile convulsion 2. Frequent episodes of epilepsy: epilepsy episodes of all types; &gt; 3 times / week 3. Refractory epilepsy: no satisfactory efficacy after treatment by 2~3 antiepileptic drugs; â‰¥ 1 time / month 4. Cerebral palsy: all types of cerebral palsy in children less than 3 years old. 1. Febrile convulsion: family history of epilepsy, complex type of febrile convulsion, epileptic episodes, febrile convulsion plus 2. Frequent episodes of epilepsy: combined with advanced diseases 3. Refractory epilepsy: epilepsy combined with advanced diseases 4. Cerebral palsy: advanced diseases combined with backwardness or retardation of brain function development.</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>